BTS-72664

N/A

Report date: 2023/02/12 00:15:45
NME

Base Information

Drug NameBTS-72664
Drug Alias NameBTS-72664
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionChloride channel agonistsSodium channels blockersGlutamate [NMDA] receptor antagonists
TargetsChloride channelSodium channelsGlutamate [NMDA] receptor
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A